Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality

被引:11
|
作者
You, Amy S. [1 ]
Sim, John J. [2 ]
Kovesdy, Csaba P. [3 ,4 ]
Streja, Elani [1 ,5 ]
Nguyen, Danh V. [6 ]
Brent, Gregory A. [7 ,8 ]
Kalantar-Zadeh, Kamyar [1 ,5 ]
Rhee, Connie M. [1 ]
机构
[1] Univ Calif Irvine, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Sch Med, Orange, CA 92668 USA
[2] Kaiser Permanente Southern Calif, Dept Nephrol, Los Angeles, CA USA
[3] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[4] Memphis Vet Affairs Med Ctr, Nephrol Sect, Memphis, TN USA
[5] Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA USA
[6] Univ Calif Irvine, Div Gen Internal Med, Orange, CA 92668 USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
[8] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
incident ESRD; mortality; pre-ESRD prelude; thyroid; transition; QUALITY-OF-LIFE; SUBCLINICAL HYPOTHYROIDISM; NONTHYROIDAL ILLNESS; FUNCTIONAL DISEASE; KIDNEY-DISEASE; HORMONE LEVELS; DOUBLE-BLIND; RISK-FACTOR; HEMODIALYSIS; TRIIODOTHYRONINE;
D O I
10.1093/ndt/gfy289
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Advanced chronic kidney disease (CKD) patients, including those receiving dialysis, have a high prevalence of thyroid dysfunction. Although hypothyroidism is associated with higher death risk in end-stage renal disease (ESRD) patients, no studies have examined whether thyroid status in the pre-ESRD period impacts mortality after dialysis initiation. Methods. Among US veterans with CKD identified from the national Veterans Affairs database that transitioned to dialysis over the period from October 2007 to September 2011, we examined the association of pre-ESRD serum thyrotropin (TSH) levels averaged over the 1-year pre-dialysis ('prelude') period with all-cause mortality in the first year following dialysis initiation. Results. Among 15 335 patients in the 1-year prelude cohort, TSH levels >5.0 mIU/L were associated with higher mortality in expanded case-mix Cox models (reference: TSH 0.5-5.0 mIU/L): adjusted hazard ratio (aHR) [95% confidence interval (CI) 1.20 (1.07-1.33). Similar findings were observed for TSH >5.0 mIU/L and mortality in the 2- and 5-year cohorts: aHRs (95% CI) 1.11 (1.02-1.21) and 1.15 (1.07-1.24), respectively. Analyses of finer gradations of TSH in the 1-year prelude cohort demonstrated that incrementally higher levels >5.0 mIU/L were associated with increasingly higher mortality in expanded case-mix models (reference: TSH 0.5-3.0 mIU/L): aHRs (95% CI) 1.18 (1.04-1.33) and 1.28 (1.03-1.59) for TSH levels >5.0-10.0 mIU/L and >10.0 mIU/L, respectively. In the 2- and 5-year cohorts, mortality associations persisted most strongly for those with TSH >10.0 mIU/L, particularly after laboratory covariate adjustment. Conclusions. Among new ESRD patients, there is a dose-dependent relationship between higher pre-ESRD TSH levels >5.0 mIU/L and post-ESRD mortality. Further studies are needed to determine the impact of TSH reduction with thyroid hormone supplementation in this population.
引用
收藏
页码:2095 / 2104
页数:11
相关论文
共 50 条
  • [1] ASSOCIATION OF CANCER HISTORY WITH MORTALITY IN END-STAGE RENAL DISEASE PATIENTS ON DIALYSIS
    Chinnadurai, Rajkumar
    Flanagan, Emma
    Kalra, Philip
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [2] Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis
    Chinnadurai, Rajkumar
    Flanagan, Emma
    Kalra, Philip A.
    [J]. JOURNAL OF NEPHROLOGY, 2019, 32 (06) : 1003 - 1009
  • [3] Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis
    Rajkumar Chinnadurai
    Emma Flanagan
    Philip A. Kalra
    [J]. Journal of Nephrology, 2019, 32 : 1003 - 1009
  • [4] Association between timing of peritoneal dialysis initiation and mortality in end-stage renal disease
    Peng Yuan
    Yang Xiao
    Chen Wei
    Yu XueQing
    [J]. 慢性疾病与转化医学(英文), 2019, 5 (01) : 37 - 43
  • [5] Mode of dialysis therapy and mortality in end-stage renal disease
    Foley, RN
    Parfrey, PS
    Harnett, JD
    Kent, GM
    O'Dea, R
    Murray, DC
    Barre, PE
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (02): : 267 - 276
  • [6] Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease
    Bao, Yeran
    Dalrymple, Lorien
    Chertow, Glenn M.
    Kaysen, George A.
    Johansen, Kirsten L.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (14) : 1071 - 1077
  • [7] Dialysis for end-stage renal disease
    Hingorani, S
    Watkins, SL
    [J]. CURRENT OPINION IN PEDIATRICS, 2000, 12 (02) : 140 - 145
  • [8] Transition-to-Dialysis Planning, Health Care Use, and Mortality in End-Stage Renal Disease
    Poonawalla, Insiya
    Barve, Kanchan
    Cockrell, Meghan
    Agarwal, Amal
    Casebeer, Adrianne W.
    Dixon, Suzanne W.
    Li, Yong
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (02): : 81 - 87
  • [9] Mortality risk in European children with end-stage renal disease on dialysis
    Chesnaye, Nicholas C.
    Schaefer, Franz
    Groothoff, Jaap W.
    Bonthuis, Marjolein
    Reusz, Gyorgy
    Heaf, James G.
    Lewis, Malcolm
    Maurer, Elisabeth
    Paripovic, Dusan
    Zagozdzon, Ilona
    van Stralen, Karlijn J.
    Jager, Kitty J.
    [J]. KIDNEY INTERNATIONAL, 2016, 89 (06) : 1355 - 1362
  • [10] Thyroid disease in end-stage renal disease
    Rhee, Connie M.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2019, 28 (06): : 621 - 630